Biolase Inc. Common Stock
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
BIOL Overview
Sector |
Health Care |
Industry |
Medical/Dental Instruments |
Previous Close |
$0.0770 |
Previous Close Volume |
3400000 |
Latest News
- BIOLASE Voluntarily Initiates Chapter 11 Proceedings Oct 01, 2024 4:05pm EDT 01 Oct 2024 16:19:28
- BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen Aug 08, 2024 4:05pm EDT 08 Aug 2024 16:19:41
- BIOLASE Announces Delisting from Nasdaq Jun 18, 2024 4:05pm EDT 18 Jun 2024 16:19:37
- Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability May 13, 2024 4:05pm EDT 13 May 2024 16:19:47
- BIOLASE to Report First Quarter 2024 Results on May 13, 2024 May 06, 2024 6:30am EDT 06 May 2024 06:34:40
- Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 Mar 21, 2024 4:05pm EDT 21 Mar 2024 16:19:45
- BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024 Mar 14, 2024 6:30am EDT 14 Mar 2024 06:34:47
- Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry Feb 22, 2024 6:30am EST 22 Feb 2024 06:49:49
- BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering Feb 15, 2024 2:45pm EST 15 Feb 2024 14:49:47
- BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering Feb 13, 2024 9:15am EST 13 Feb 2024 10:04:48
- BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024 Jan 29, 2024 6:30am EST 29 Jan 2024 06:34:48